Applied Sciences,
Journal Year:
2023,
Volume and Issue:
13(8), P. 4872 - 4872
Published: April 13, 2023
The
COVID-19
pandemic
has
impacted
the
health
of
millions
people
worldwide,
with
many
survivors
experiencing
persistent
symptoms
and
long-term
disabilities
[...]
BMC Infectious Diseases,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: June 21, 2023
Lingering
symptoms
after
acute
COVID-19
present
a
major
challenge
to
ambulatory
care
services.
Since
there
are
reservations
regarding
their
optimal
management,
we
aimed
collate
all
available
evidence
on
the
effects
of
rehabilitation
treatments
applicable
in
for
these
patients.
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: March 21, 2024
Introduction
Long
COVID
patients
experience
a
decrease
in
their
quality
of
life
due
to
the
symptomatology
produced
by
disease.
It
is
also
important
understand
how
long
affects
both
men
and
women.
The
objective
this
study
examine
impact
on
Spanish
adults
from
gender
perspective.
Methods
An
observational
cross-sectional
was
carried
out.
Participants
were
able
complete
an
online
questionnaire
using
platform.
A
sample
206
people
participated
study.
Results
80.6%
women
with
mean
age
46.51
(±8.28)
19.4%
48.03
(±9.50).
medium
score
PAC19-QoL
test
141.47
(±24.96)
segmented
gender,
141.65
(±23.95)
for
140.82
(±28.66)
men.
most
common
symptoms
muscle
joint
pain
(94.6%),
fatigue
(94.0%),
discomfort
(92.2%),
difficulty
concentrating
(91.0%),
memory
loss
(88.6%).
For
included
(97.5%)
occupying
first
position,
(92.0%),
(90.0%),
mood
disturbances
(87.5%).
chi-square
showed
statistical
significance
(
p
<
0.005)
socio-demographic
information,
scores,
intensities.
Conclusion
This
shows
that
there
are
differences
way
experienced.
European Archives of Psychiatry and Clinical Neuroscience,
Journal Year:
2024,
Volume and Issue:
274(8), P. 1829 - 1845
Published: Jan. 3, 2024
Abstract
Post-acute
sequelae
of
COVID-19
can
present
as
multi-organ
pathology,
with
neuropsychiatric
symptoms
being
the
most
common
symptom
complex,
characterizing
long
COVID
a
syndrome
significant
disease
burden
for
affected
individuals.
Several
typical
COVID,
such
fatigue,
depressive
and
cognitive
impairment,
are
also
key
features
other
psychiatric
disorders
myalgic
encephalomyelitis/chronic
fatigue
(ME/CFS)
major
disorder
(MDD).
However,
clinically
successful
treatment
strategies
still
lacking
often
inspired
by
options
diseases
similar
clinical
presentations,
ME/CFS.
Acetylcarnitine,
shortest
metabolite
class
fatty
acid
metabolites
called
acylcarnitines
one
abundant
blood
in
humans
be
used
dietary/nutritional
supplement
proven
efficacy
MDD,
ME/CFS
disorders.
Basic
research
recent
decades
has
established
general,
acetylcarnitine
particular,
important
regulators
indicators
mitochondrial
function
physiological
processes
neuroinflammation
energy
production
pathways.
In
this
review,
we
will
compare
basis
fatigue-associated
diseases.
We
review
molecular
mechanisms
associated
altered
metabolism
potential
to
interfere
these
therapeutic
agent.
Finally,
current
evidence
propose
future
investigate
option
COVID.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(7), P. 1287 - 1287
Published: April 7, 2025
Long
COVID,
characterized
by
persistent
symptoms
following
COVID-19
infection,
significantly
impacts
individuals'
health
and
daily
functioning
due
to
fatigue
pain.
Focusing
on
pain,
this
review
addresses
nociplastic
chronic
pain
conditions.
Interventions
designed
reduce
inflammation,
oxidative
stress,
enhance
vagal
activity
may
offer
a
promising
approach
managing
post-pandemic
This
presents
individual
components
of
food
supplements
with
demonstrated
efficacy
in
one
or
more
conditions,
focusing
their
proposed
mechanisms
clinical
including
use
post-COVID-19
when
available.
Many
these
substances
have
long
history
safe
an
alternative
long-term
analgesic
drug
treatment,
which
is
often
associated
potential
side
effects.
also
explores
the
for
synergistic
effects
combining
each
other
conventional
analgesics,
considering
advantages
both
patients
healthcare
system
using
as
adjunctive
primary
therapies
related
COVID.
While
preclinical
scientific
literature
provides
mechanistic
basis
action
several
control
signaling
pathways,
experience,
particularly
field
COVID-associated
still
limited.
However,
reviewed
strongly
suggests
that
attainable
goal,
provided
rigorous
trials
are
conducted.
Medicina,
Journal Year:
2023,
Volume and Issue:
59(12), P. 2197 - 2197
Published: Dec. 18, 2023
Background
and
Objectives:
In
the
Western
world,
back
pain
sciatica
are
among
main
causes
of
disability
absence
from
work
with
significant
personal,
social,
economic
costs.
This
prospective
observational
study
aims
to
evaluate
effectiveness
a
rehabilitation
program
combined
administration
Alpha
Lipoic
Acid,
Acetyl-L-Carnitine,
Resveratrol,
Cholecalciferol
in
treatment
due
herniated
discs
young
patients
terms
resolution,
postural
alterations,
taking
painkillers,
quality
life.
Materials
Methods:
A
was
conducted
on
128
sciatica.
We
divided
sample
into
3
groups:
Combo
group,
which
received
combination
protocol
daily
therapy
600
mg
1000
50
800
UI
for
30
days;
Reha
only
protocol;
Supplement
oral
supplementation
Cholecalciferol.
Clinical
assessments
were
made
at
time
recruitment
(T0),
days
after
start
(T1),
60
end
(T2).
The
rating
scales
as
follows:
Numeric
Rating
Scale
(NRS);
Oswestry
Disability
Questionnaire
(ODQ);
36-item
Short
Form
Health
Survey
(SF-36).
All
also
underwent
an
instrumental
stabilometric
evaluation.
Results:
At
T1,
group
showed
statistically
superior
results
compared
other
groups
(p
<
0.05),
life
0.05).
T2,
0.05)
From
analysis
evaluation
data,
we
observed
improvement
T2
average
X
groups.
Conclusions:
supplements
anti-inflammatory,
pain-relieving,
antioxidant
action
is
effective
can
be
useful
improving
stability.
F1000Research,
Journal Year:
2023,
Volume and Issue:
12, P. 368 - 368
Published: May 24, 2023
Background:
A
diverse
spectrum
of
long
COVID
symptoms
(LCS)
have
the
scope
physical
rehabilitation.
Due
to
limited
resources,
very
little
is
known
about
physiotherapy
and
rehabilitation
interventions
for
LCS
their
clinical
application.
This
study
aims
explore
role
in
management
musculoskeletal,
neurological,
cognitive,
cardiorespiratory,
mental
health,
functional
impairments
LCS.Methods:
The
was
a
systematic
scoping
review
literature
published
between
April
2020
July
2022.Results:
87
articles
were
extracted
followed
by
standard
process
Preferred
Reporting
Items
Systematic
reviews
meta-analysis
(PRISMA)
extension
Scoping
(PRISMA-ScR).
included
studies
had
3223
population.
All
types
primary
secondary
retrieved
except
qualitative
studies.
evidence
evaluated
an
appraisal
scoring
tool
guidelines
“Enhancing
Quality
Transparency
Health
Research
(
EQUATOR)
network”.
papers
mean
score
0.7807
on
0
1
scale
(SD
0.08),
minimum
protocols
(0.5870),
maximum
Cohort
(.8977).
Sixty
seven
(67)
evidence-based
documented
from
17
categories.
most
weighted
treating
underlying
(Adjusted
1/1),
fatigue
0.963/1),
aerobic
exercise
balance
training
0.951/1),
multidisciplinary
0.926/1),
low
resistance
0.889/1).Conclusion:
We
recommend
Long
approach
individual
symptoms,
especially
fatigue.
Physiotherapy
play
significant
as
recommended
exercise,
modalities,
patient
education,
respiratory
rehabilitation,
telerehabilitation
do
not
require
protocol
registration
ns4:href="https://www.crd.york.ac.uk/PROSPERO/">PROSPERO.
Sensors,
Journal Year:
2023,
Volume and Issue:
23(13), P. 5880 - 5880
Published: June 25, 2023
A
new
pandemic
was
declared
at
the
end
of
2019
because
coronavirus
disease
(COVID-19).
One
effects
COVID-19
infection
is
anosmia
(i.e.,
a
loss
smell).
Unfortunately,
this
olfactory
dysfunction
persistent
in
around
5%
world's
population,
and
there
not
an
effective
treatment
for
it
yet.
The
aim
paper
to
describe
potential
non-invasive
neurostimulation
strategy
treating
post-COVID-19
patients.
In
order
design
strategy,
25
subjects
who
experienced
due
underwent
assessment
while
their
electroencephalographic
(EEG)
signals
were
recorded.
These
used
investigate
activation
brain
regions
during
process
identify
which
would
be
suitable
neurostimulation.
Afterwards,
15
participated
evaluation
based
on
applying
transcranial
direct
current
stimulation
(tDCS)
selected
related
function.
results
showed
that
with
lower
scores
obtained
greater
improvement
than
other
subjects.
Thus,
tDCS
could
promising
option
people
have
fully
regained
sense
smell
following
infection.
Applied Sciences,
Journal Year:
2022,
Volume and Issue:
12(14), P. 7310 - 7310
Published: July 20, 2022
Many
critically
ill
patients
infected
with
SARS-CoV-2
have
been
submitted
to
an
intensive
care
unit
(ICU).
Patients
a
infection
that
survive
critical
illness
are
confronted
months
of
physical
impairments.
To
maximize
recovery,
it
is
important
understand
the
musculoskeletal
involvement
in
SARS-CoV-2.
The
aim
present
study
was
assess
myocellular
changes
occur
throughout
first
week
ICU
admission.
In
n
=
22
SARS-CoV-2,
biopsy
sample
from
vastus
lateralis
muscle
obtained
at
day
1–3
and
5–8
following
Fluorescence
microscopy
used
type
I
II
fiber
size
distribution,
myonuclear
content,
tissue
capillarization.
Transmission
electron
support
quantitative
data
ultrastructural
level.
Changes
showed
large
inter-individual
variation.
average
change
+309
±
1834
µm2,
ranging
−2129
µm2
(−31%)
+3375
(+73%).
−224
1256
−1410
(−36%)
+2592
(+48%).
Ultrastructural
observations
myofibrillar
hydropic
degeneration,
necrosis.
This
shows
admitted
suffer
substantial
damage
during
These
results
call
for
action
towards
more
specialized
rehabilitation
programs
infection.
F1000Research,
Journal Year:
2023,
Volume and Issue:
12, P. 368 - 368
Published: April 5, 2023
Background:A
diverse
spectrum
of
long
COVID
symptoms
(LCS)
have
the
scope
physical
rehabilitation.
Due
to
limited
resources,
very
little
is
known
about
physiotherapy
and
rehabilitation
interventions
for
LCS
their
clinical
application.
This
study
aims
explore
role
in
management
musculoskeletal,
neurological,
cognitive,
cardiorespiratory,
mental
health,
functional
impairments
LCS.Methods:The
was
a
systematic
scoping
review
literature
published
between
April
2020
July
2022.Results:87
articles
were
extracted
followed
by
standard
process
The
Preferred
Reporting
Items
Systematic
reviews
meta-analysis
(PRISMA)
extension
Scoping
(PRISMA-ScR).
included
studies
had
3223
population.
All
types
primary
secondary
retrieved
except
qualitative
studies.
evidence
evaluated
an
appraisal
scoring
tool
guidelines
“Enhancing
Quality
Transparency
health
Research
(EQUATOR)
network”.
papers
mean
score
0.7807
on
0
1
scale
(SD
0.08),
minimum
protocols
(0.5870),
maximum
Cohort
(.8977).
Sixty
seven
(67)
evidence-based
documented
from
17
categories.Conclusion:LCS
can
be
treated
physiotherapy,
exercise,
cardio-respiratory,
at
home
or
setups
such
as
care
settings
in-person
telerehabilitation.
Frontiers in Rehabilitation Sciences,
Journal Year:
2024,
Volume and Issue:
5
Published: Oct. 18, 2024
Background
For
many
people
with
long
COVID
(LC),
new-onset
pain
is
a
debilitating
consequence.
This
study
examined
the
nature
of
and
concomitant
symptoms
in
patients
LC
to
infer
mechanisms
from
relationships
between
health-related
factors.
Methods
Pain
other
were
evaluated
153
individuals
using
Self-Administered
Leeds
Assessment
Neuropathic
Symptoms
Signs,
EuroQoL
Visual
Analog
Scale,
Quality
Life
Neurological
Disorders.
The
patient
factors
analyzed
Chi
Square
independent
t
-tests.
Results
20.3%
who
reported
had
neuropathic
pain,
which
was
associated
lower
quality
life
higher
rates
cognitive
dysfunction
compared
those
non-neuropathic
pain.
Other
similar
groups,
however
heart-related
more
prevalent
mood
swings
for
Conclusions
Characterizing
NP
can
aid
developing
better
clinical
management
strategies.
Understanding
associations
provides
imperative
foundation
future
studies
further
examining
pathophysiological
underlying
development
LC.